FALMOUTH, Mass., May 10, 2024
/PRNewswire/ -- Associates of Cape Cod Inc. (ACC), a Seikagaku
Group Company, is marking 50 years of innovation and safeguarding
public health with a new brand identity, embodying the company's
enduring legacy and forward-looking vision. Along with a new logo,
the global company, headquartered in Falmouth, Massachusetts, is updating its brand
name to ACC.
In 1974, ACC perfected the modern process of bacterial endotoxin
testing using limulus amebocyte lysate (LAL) from horseshoe crab
blood. Approved by the FDA in 1977, this critical process has since
become the industry's gold standard. Upholding our brand promise of
"Protection Through Detection," ACC has steadfastly provided
high-quality products and services for endotoxin and
(1,3)‐β‐D-glucan testing. Providing a critical quality control
release test for pharmaceutical injectables, medical devices and
renal disease, as well as clinical diagnostic screening to aid in
the early diagnosis of invasive fungal infection, ACC has enabled
testing that has protected millions of patients.
As ACC honors its historic roots and achievements, it also looks
to the future with the PyroSmart NextGen® recombinant
cascade reagent (rCR), a sustainable biotechnology that replicates
the LAL enzyme cascade and requires no horseshoe crab blood,
demonstrating our unwavering commitment to environmental
stewardship and innovation.
Considering these milestones, ACC has decided it's time to step
into a new era with a brand identity that reflects our position as
a leading biotech company dedicated to innovation, sustainability,
and safeguarding global health.
"Today is not just about celebrating our history but embracing a
future where we continue to innovate responsibly," said Dr. A.J.
Meuse, President and CEO of ACC. "Our new brand identity reflects
our dedication to protecting patients and our respect for the
natural world that has enabled our advancements over the last 50
years."
ACC's new branding will appear in promotional materials, at
trade shows and other events, on the company's website, and in its
facilities.
As it celebrates this milestone, ACC reaffirms its commitment to
quality, cost management, and sustainable practices every day. As
we look back on our history with pride, we also look forward to a
future of enduring contributions to health and science.
About ACC — A Seikagaku Group Company
Specializing in
recombinant and traditional chromogenic and turbidimetric reagent
technologies, ACC has been a global leader in endotoxin and (1,3)‐β
‐D‐glucans detection products and services for 50 years. ACC
pioneered modern LAL testing methodology and was the first U.S.
FDA-licensed company to manufacture LAL reagents; ACC is today
recognized as an international leader in endotoxin detection. Visit
www.acciusa.com for more information.
For further information, contact:
Vann Jones – Director, Global Marketing
ACC
Falmouth, MA
USA
Phone:888‐395‐2221
VJones@acciusa.com
www.acciusa.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/associates-of-cape-cod-inc-acc-marks-50-years-of-protection-through-detection-with-a-new-look-302142460.html
SOURCE Associates of Cape Cod,
Inc.